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The effects of 1,25-dihydroxyvitamin D3 on the
differentiation of immature melanocyte precursors
were studied. The NCC-/melb4 cell line is an imma-
ture melanocyte cell line established from mouse
neural crest cells. 1,25-dihydroxyvitamin D3 inhibi-
ted the growth of NCC-/melb4 cells at concentra-
tions higher than 10±8 M. That growth inhibition was
accompanied by the induction of tyrosinase and a
change in L-3,4-dihydroxyphenylalanine reactivity
from negative to positive. Electron microscopy dem-
onstrated that melanosomes were in more advanced
stages after 1,25-dihydroxyvitamin D3 treatment. In
primary cultures of murine neural crest cells, L-3,4-
dihydroxyphenylalanine-positive cells were increased
after 1,25-dihydroxyvitamin D3 treatment. These
®ndings indicate that 1,25-dihydroxyvitamin D3
stimulates the differentiation of immature melano-
cyte precursors. Moreover, immunostaining and
reverse transcription±polymerase chain reaction
analysis revealed that endothelin B receptor expres-
sion was induced in NCC-/melb4 cells following
treatment with 1,25-dihydroxyvitamin D3. The
induction of endothelin B receptor by 1,25-di-
hydroxyvitamin D3 was also demonstrated in neural
crest cell primary cultures, but not in mature
melanocytes. The expression of microphthalmia-
associated transcription factor was induced in
NCC-/melb4 cells treated with 1,25-dihydroxy-
vitamin D3 and endothelin 3, but not by 1,25-
dihydroxyvitamin D3 alone, suggesting that endo-
thelin 3 may stimulate the expression of the micro-
phthalmia-associated transcription factor gene after
binding to the endothelin B receptor induced by
1,25-dihydroxyvitamin D3. These ®ndings suggest a
regulatory role for vitamin D3 in melanocyte
development and melanogenesis, and may also
explain the working mechanism of vitamin D3 in the
treatment of vitiligo. Key words: endothelin 3/melano-
genesis/microphthalmia-associated transcription factor/
vitamin D receptor/vitamin D3. J Invest Dermatol
118:583±589, 2002
T
he active metabolite of vitamin D, namely 1,25-
dihydroxyvitamin D3 (1,25(OH)2D3), is known for its
regulatory role in calcium homeostasis. The hormone,
derived either from 7-dehydrocholesterol by the
action of ultraviolet light on the skin or from the
diet, facilitates the absorption of calcium from the intestine, its
mobilization from bone, and its resorption in the kidney (Burgos-
Trinidad et al, 1990; De Luca et al, 1990; Studzinski et al, 1993).
Apart from its role in calcium uptake, 1,25(OH)2D3 is widely
acknowledged to be an important regulator of cell growth and
differentiation (Lowe et al, 1992; Darwish and De Luca, 1993;
Nemere et al, 1993).
The biologic responses elicited by 1,25(OH)2D3 have primarily
been attributed to the activation of the nuclear vitamin D receptor
(VDR) (Haussler, 1986), which is a member of the superfamily of
nuclear steroid/thyroid receptors. After binding 1,25(OH)2D3, the
receptors form homodimers and heterodimers with other members
of the superfamily and act as transcription factors for a variety of
genes (Carlberg, 1993). This is referred to as the classic genomic
effect of 1,25(OH)2D3 because it involves gene transcription and
new protein synthesis.
Vitamin D3 stimulates the differentiation and inhibits the
proliferation of many different types of tumor cells, including a
variety of melanoma cell lines. Murine B16 melanoma cells treated
with vitamin D3 exhibit an increase in tyrosinase activity and
melanogenesis (Oikawa and Nakayasu, 1974). A signi®cant growth
inhibition was noted in human melanoma cell lines treated with
vitamin D3 (Evans et al, 1996). There has been a report showing
that vitamin D3 did not affect melanization of cultured human
melanocytes (Mansur et al, 1988), but in apparent contrast, Tomita
et al (1988) showed that vitamin D3 increased the tyrosinase content
of cultured human melanocytes. Topical application of vitamin D3
to the epidermis of mice increases the number of L-3,4-
dihydroxyphenylalanine (DOPA)-positive melanocytes (Abdel-
Malek et al, 1988). These ®ndings suggest a possible role for
vitamin D3 in modulating melanogenesis, but little is known
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concerning the effect of 1,25(OH)2D3 on the differentiation of
melanocyte precursors or cultured neural crest cells (NCC).
We have established an immortal cell population of NCC from
WB Sl/+ or +/+ mice, and have designated it as NCC-S4.1 (Kawa
et al, 2000). From NCC-S4.1 cells, we obtained a cloned cell line
named NCC-melb4 by a single-cell cloning method (Kawa et al,
2000). NCC-melb4 cells are immature melanocyte precursors, as
they are positive for tyrosinase-related protein-1 and -2 and KIT,
but are negative for tyrosinase, endothelin B receptor (EDNRB),
and DOPA reaction (Watabe et al, 2002). They are immortal and
stable when maintained in a culture medium supplemented with
stem cell factor (SCF). Their growth is not dependent on
endothelin 3 (EDN3), probably because of their lack of EDNRB
expression. We have also obtained a cloned cell line named NCC-
melan5 from C57BL/6 mice (Ooka et al, 2001). NCC-melan5 cells
require SCF and EDN3 in the culture medium. They appear to be
mature melanocytes, as they are positive for tyrosinase, tyrosinase-
related protein-1 and -2, KIT, EDNRB, and DOPA reactions.
Using these cell lines and mouse NCC in a primary culture system,
the effects of 1,25(OH)2D3 on the differentiation of the cells and
their expression of EDNRB were investigated.
MATERIALS AND METHODS
Mice C57BL/6 mice purchased from Japan SLC Co., Ltd.
(Hamamatsu, Japan) were mated, and the embryos from those matings
were used at 9.5 d postcoitum (E9.5).
Cells and culture conditions NCC-melb4 cells were established using
a single cell cloning method from an immortal cell population (NCC-
S4.1) obtained from NCC derived from WB Sl/+ or +/+ mice (Kawa
et al, 2000). NCC-melan5 cells were established from NCC of C57BL/6
mice (Ooka et al, 2001). NCC-melb4 cells were grown in Eagle's
modi®ed essential medium supplemented with 5% fetal bovine serum
and 50 ng per ml recombinant mouse SCF (kindly supplied by Kirin
Brewery, Tokyo, Japan). NCC-melan5 cells were grown in Eagle's
modi®ed essential medium containing 15% fetal bovine serum, 50 ng per
ml recombinant mouse SCF, and 100 nM EDN3 (Peptide Institute Inc,
Osaka, Japan). 1,25(OH)2D3 (BIOMOL Research Laboratories, Inc,
Plymouth Meeting, PA) was dissolved in ethanol at a concentration of
10±4 M as a stock solution, and then was added to the culture medium at
a ®nal concentration of 10±7 M, unless indicated otherwise.
Proliferation assay Cells were plated at 2000 cells per well in 96-well
plates. On the next day various concentrations of 1,25(OH)2D3 were
added to the culture medium (day 0). On day 5, the cells were
incubated with alamar blue dye (Trek Diagnostic Systems, Inc, Westlake,
OH) for 4 h and the ¯uorescence was measured using a Fluoroskan II
microplate reader (Labsystems, Helsinki, Finland)
Immunohistochemistry The antibody to tyrosinase (aPEP7, which
recognizes the carboxy terminus of tyrosinase, Jimenez et al, 1991) were
kindly supplied by Dr Hearing (NIH, Bethesda, MD). Cells ®xed with
95% ethanol at room temperature were treated with antibodies against
tyrosinase, EDNRB (IBL, Maebashi, Japan) or VDR (Diagnostic System
Laboratories, Webster, TX) as described previously (Kawa et al, 2000;
Ooka et al, 2001; Watabe et al, 2002). They were then reacted with
alkaline phosphatase-labeled anti-rat IgG (Southern Biotechnology
Associates, Birmingham, LA) or rabbit IgG (DAKO, Carpinteria, CA)
and developed using the New Fuchsin Substrate System (DAKO).
DOPA reaction and electron microscopy Cells were ®xed with 2%
paraformaldehyde at room temperature and were then treated with 0.1%
DOPA (Sigma, St Louis, MO) in 0.1 M phosphate buffer (pH 7.2) for
5 h at 37°C. Nuclei were stained by Nuclear fast red (Merck, Darmstadt,
Germany). Electron microscopy and electron microscopic DOPA
staining were performed as described elsewhere (Kawa et al, 2000).
RNA extraction and reverse transcription±polymerase chain
reaction (reverse transcription±PCR) analysis Total RNA was
extracted from the cells using an RNA isolation kit (QIAGEN, Hilden,
Germany) as described by the manufacturer. cDNA was prepared from
10 mg total RNA using MMLV Reverse Transcriptase (Gibco/BRL,
Gaithersburg, MD). PCR reactions consisted of 34 cycles for tyrosinase
and microphthalmia-associated transcription factor (MITF), 35 cycles for
EDNRB or 40 cycles for VDR. PCR reactions were initiated with a
``cold start''; denaturation at 98°C for 10 s (tyrosinase and MITF), at
95°C for 60 s (EDNRB) or at 94°C for 10 s (VDR), annealing at 60°C
for 30 s (tyrosinase and MITF), at 60°C for 60 s (EDNRB) or at 58°C
for 60 s (VDR), polymerization at 72°C for 60 s (tyrosinase and MITF),
at 72°C for 120 s (EDNRB) or at 72°C for 30 s (VDR). The primer
sequences used were as follows:
Tyrosinase sense primer 5¢-CTATGTCATCCCCACAGGCAC-3¢
Tyrosinase anti-sense primer 5¢-TTACCTGCCAGGAGGAGAAGA-3¢
MITF sense primer 5¢-AGTCACTACCAGGTGCAGAC-3¢
MITF anti-sense primer 5¢-CTTGCTTCAGACTCTGTGGG-3¢
EDNRB sense primer 5¢-CGAGCTGTTGCTTCTTGGAGTAG-3¢
EDNRB anti-sense primer 5¢-AACGGAAGTTGTCATATCCGTGAT-3¢
VDR sense primer 5¢-AGATGACCCTTCTGTGACCC-3¢
VDR anti-sense primer 5¢-AGCTTCTTCAGTCCCACCTG-3¢
b-actin primers were from Promega, Inc. (Madison, WI). PCR
products were resolved in 2% agarose gels containing ethidium bromide
in parallel with DNA molecular weight markers.
Western blot analysis Cells were harvested by scraping, collected by
centrifugation, and were then lyzed in cell lysis buffer (1% Triton
X-100, 10 mM Tris±HCl, pH 7.4). Cell lysates were separated on 10%
sodium dodecyl sulfate polyacrylamide gels. After electrophoresis,
proteins on the gel were electroblotted on to nitrocellulose ®lters that
were then incubated for 2 h in Tris-buffered saline (100 mM NaCl,
50 mM Tris±HCl, pH 7.2) containing 2.5 mg per ml nonfat powdered
milk (Tris-buffered saline milk). The ®lters were then incubated
overnight in the presence of the tyrosinase antibody (aPEP7, 1 : 500)
and was then reacted with alkaline Anti-phosphatase-labeled anti-rabbit
IgG (DAKO) for 90 min. The ®lters were washed in Tris-buffered saline
milk and the antigens were detected with 5-bromo-4-chloro-3-indolyl
phosphate (Sigma) and nitroblue tetrazodium (Sigma).
NCC culture The NCC culture method was that described by Ito and
Takeuchi (1984). Trunk regions posterior to the forelimb buds were
dissected from E9.5 embryos of C57BL/6 mice using tungsten needles.
The trunks were individually treated with 1% trypsin (Difco, Detroit,
MI) in Tyrode's solution for 20 min at 4°C. Trypsinization was
terminated by washing with Tyrode's solution containing 10% fetal
bovine serum. The tissues were gently pipetted with small pore Pasteur
pipettes to separate the neural tubes from other components of the
trunks. Neural tubes were explanted individually in 12-well plates with
Eagle's modi®ed essential medium containing 15% fetal bovine serum
and 50 ng per ml recombinant mouse SCF. The explants were ®xed at
13 d in culture and were then subjected to DOPA reaction or
immunohistochemistry.
Statistical analysis Student's t test was used for statistical analysis.
RESULTS
Inhibitory effects of 1,25(OH)2D3 on the proliferation of
NCC-melb4 cells We studied whether 1,25(OH)2D3 affected
the proliferation of NCC-melb4 cells (Fig 1). Cellular proliferation
was inhibited by 1,25(OH)2D3 in a concentration-dependent
manner and was markedly inhibited at concentrations higher than
10±8 M. Equivalent amounts of vehicle (ethanol) alone had no
effects on the cell growth (data not shown).
Differentiation of NCC-melb4 cells induced by
1,25(OH)2D3 As NCC-melb4 cells are immature melanocytes,
we considered that the growth inhibition elicited by 1,25(OH)2D3
might be associated with their differentiation. We then examined
the effects of 1,25(OH)2D3 on the expression of tyrosinase and
DOPA reactivity as markers of differentiation. NCC-melb4 cells
were initially negative for tyrosinase and DOPA reactivity
(Fig 2a,c). Presumably because NCC-melb4 was a cloned cell
line, all cells were negative for both reaction without exception.
After 72 h of treatment with 1,25(OH)2D3, some but not all of
them became tyrosinase positive and DOPA positive (Fig 2b,d).
The induction of tyrosinase by 1,25(OH)2D3 was also
demonstrated by western blot analysis (Fig 3a) and by reverse
transcription±PCR analysis (Fig 3b). These results suggest that
1,25(OH)2D3 stimulates the differentiation of immature
melanocyte precursors.
1,25(OH)2D3 induces EDNRB expression Next we
examined whether 1,25(OH)2D3 affects EDNRB expression in
NCC-melb4 cells. The cells were originally negative for EDNRB
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(Fig 2e), but after 72 h of treatment with 10±7 M 1,25(OH)2D3,
some but not all of them became EDNRB positive (Fig 2f). To
study the induction of EDNRB by 1,25(OH)2D3 at the molecular
level, reverse transcription±PCR analysis was performed. As shown
in Fig 4(a,b), 1,25(OH)2D3 induced the expression of EDNRB
mRNA in NCC-melb4 cells at 10±7 M and 10±8 M, but not at
10±9 M. We then investigated whether 1,25(OH)2D3 alters
EDNRB expression in NCC-melan5 cells, which are EDNRB-
positive mature melanocytes (Ooka et al, 2001). As shown in
Fig 4(c), 1,25(OH)2D3 had no effect on the expression of EDNRB
mRNA in NCC-melan5 cells, although NCC-melb4 cells and
NCC-melan5 cells expressed VDR mRNA, as demonstrated by
reverse transcription±PCR analysis (Fig 5).
Differentiation of NCC-melb4 cells after 1,25(OH)2D3
treatment at the ultrastructural level Electron microscopy
and ultrastructural DOPA staining are shown in Fig 6. Before
treatment with 1,25(OH)2D3, NCC-melb4 cells contained stage I
melanosomes only, none being in more advanced stages, and they
were DOPA negative. After 72 h of treatment with 1,25(OH)2D3,
stage III±IV melanosomes became apparent, and DOPA staining
was positive in the Golgi areas and in melanosomes.
The combination of 1,25(OH)2D3 and EDN3 induces
MITF expression NCC-melb4 cells were incubated with
1,25(OH)2D3 alone or in the presence of EDN3 for 72 h, and
were then tested for MITF expression by reverse transcription±
PCR analysis (Fig 7). The combination of 1,25(OH)2D3 and
EDN3 induced MITF mRNA expression, whereas 1,25(OH)2D3
alone did not. This suggests a possible role for EDNRB signaling in
the induction of MITF, and that EDNRB induced by
1,25(OH)2D3 may effectively transduce signals that stimulate
MITF expression.
EDNRB-positive cells and DOPA-positive cells increases in
NCC cultures after 1,25(OH)2D3 treatment We investigated
the effect of 1,25(OH)2D3 on the NCC primary culture system.
Explants from C57BL/6 mice embryos contained VDR-positive
cells in NCC around the periphery of the epithelial sheets (data not
shown). Before treatment with 1,25(OH)2D3, the explants were
negative for EDNRB, but after 1,25(OH)2D3 treatment, EDNRB-
positive cells appeared in NCC around the periphery of the
epithelial sheets (Fig 8). As shown in Fig 9, an increase in DOPA-
positive cells was seen following treatment of the NCC cultures
with 1,25(OH)2D3.
DISCUSSION
Various factors, including SCF, EDN3, 12-O-tetradecanoyl-
phorbol-13-acetate, and cholera toxin, have been shown to
stimulate the differentiation of melanocyte precursors (Murphy
Figure 3. Enhanced expression of tyrosinase after 1,25(OH)2D3
treatment. Tyrosinase expression in NCC-melb4 cells before and after
the treatment with 10±7 M 1,25(OH)2D3 for 72 h was determined by
western blotting (a) and by reverse transcription±PCR analysis (b) as
described in Materials and Methods. (b) Lanes 1 and 2: b-actin; lanes 3 and
4: tyrosinase.
Figure 1. 1,25(OH)2D3 inhibits cell proliferation in a
concentration-dependent manner. NCC-melb4 cells were plated at
2000 cells per well in 96-well plates and were incubated with various
concentrations of 1,25(OH)2D3. After 5 d, cells were incubated with
alamar blue dye and the ¯uorescence was measured on a microplate
reader. **p < 0.01.
Figure 2. Effects of 1,25(OH)2D3 on tyrosinase expression,
DOPA reaction and EDNRB expression. NCC-melb4 cells before
(a,c,e) and after (b,d,f) treatment with 10±7 M 1,25(OH)2D3 for 72 h
were immunohistochemically stained for tyrosinase (a,b) or EDNRB
(e,f), or were tested for DOPA reaction (c,d). Scale bar = 10 mm.
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et al, 1992; Ito et al, 1993; Ono et al, 1998), but the effect of
1,25(OH)2D3 on the differentiation of melanocyte precursors and
on NCC cultures has not yet been established. VDR expression has
been detected in several cancer cell lines, including colon
carcinoma, breast carcinoma, and malignant melanoma (Colston
et al, 1981; Frampton et al, 1982), and in human melanocytes in vivo
(Milde et al, 1991). In this study, we show that VDR mRNA is
expressed in two murine NCC lines, i.e., NCC-melb4 and NCC-
melan5, and that neural crest explants from C57BL/6 mice
embryos contain VDR-positive cells in NCC around the periphery
of the epithelial sheets, which suggests a possible role for vitamin D
in regulating the proliferation and differentiation of melanocyte
precursors.
In this study, we show that 1,25(OH)2D3, which is the active
metabolite of vitamin D, inhibits the growth of NCC-melb4 cells.
That growth inhibition is accompanied by the induction of
tyrosinase and a change in DOPA reactivity from negative to
positive. Electron microscopy demonstrates the presence of
melanosomes at more advanced stages in 1,25(OH)2D3-treated
cells, compared with untreated cells. In primary NCC cultures,
DOPA-positive cells are increased after 1,25(OH)2D3 treatment.
These ®ndings indicate that 1,25(OH)2D3 may stimulate the
differentiation of immature melanocyte precursors.
Endothelins (EDN1, EDN2, EDN3) are paracrine signal
peptides (21 amino acid residues in length) that bind to at least
two subtypes of G-protein-coupled heptahelical receptors
(EDNRA and EDNRB). Those two receptors share high sequence
homology (Elshourbagy et al, 1993), but can be distinguished by
their speci®city; however, EDNRA binds EDN1 and EDN2 with
higher af®nity, all three EDN are bound equally well by EDNRB
(Sakurai et al, 1992). EDN were shown to be bound by normal
human melanocytes that respond with increased proliferation and
pigmentation (Yada et al, 1991; Imokawa et al, 1992, 1995, 1997).
EDN3 also promotes the survival and proliferation of melanocyte
precursors (Lahav et al, 1996, 1998; Ono et al, 1998). The
expression of EDNRB is directly regulated by tumor necrosis factor
a in human endothelial cells (Smith et al, 1998), but the regulation
of EDNRB expression in melanocyte precursors remains un-
known.
Immunostaining and reverse transcription±PCR analysis shown
in this study reveal the induction of EDNRB by 1,25(OH)2D3 in
NCC-melb4 cells and also in NCC primary cultures. These
®ndings indicate that 1,25(OH)2D3 acts to promote the expression
of EDNRB in immature melanocyte precursors, and they also
suggest a possible role for 1,25(OH)2D3 in modulating melanocyte
development in vivo. To the best of our knowledge, this is the ®rst
study reporting the effect of vitamin D3 on EDNRB expression,
and moreover, no other factors have been shown to stimulate
EDNRB expression in melanocytes or in immature melanocyte
precursors. Recently, we showed that all-trans retinoic acid induces
the differentiation of NCC-melb4 cells, but that it did not induce
EDNRB (Watabe et al, 2002). We have also studied whether other
factors, such as SCF, EDN, 12-O-tetradecanoyl-phorbol-13-acet-
ate, or cholera toxin, induce EDNRB on NCC-melb4 cells and
found that none of them did (data not shown). Therefore, the
induction of EDNRB on melanocyte precursors may be a speci®c
function of 1,25(OH)2D3. As EDNRB is one of the marker
molecules for mature melanocytes, vitamin D3 may be an essential
factor in melanocyte development. Reverse transcription±PCR
analysis showed that 1,25(OH)2D3 had no effect on the expression
of EDNRB in NCC-melan5 cells (EDNRB-positive mature
melanocytes), suggesting that 1,25(OH)2D3 may stimulate
EDNRB expression by immature melanocyte precursors such as
NCC-melb4 cells but not in mature melanocytes such as NCC-
melan5 cells.
MITF is the human homolog of the mouse microphthalmia (mi)
gene product, which is a novel transcription factor of the basic±
helix±loop±helix (bHLH)±leucine zipper protein family
(Hodgkinson et al, 1993; Hughes et al, 1993; Tachibana et al,
1994). MITF is able to direct melanocyte-speci®c transcription of
the tyrosinase and tyrosinase-related protein-1 genes (Yasumoto et
al, 1994, 1997), and is thought to be involved in regulating the
differentiation and maintenance of melanocytes (Tachibana, 1997,
2000). It has been suggested that EDN may regulate MITF
function at the protein and promoter levels (Tachibana, 2000). This
study demonstrates that 1,25(OH)2D3 combined with EDN3
induces MITF expression in NCC-melb4 cells, whereas
1,25(OH)2D3 alone does not. Thus, EDN3 may induce expression
Figure 4. EDNRB expression is induced by 1,25(OH)2D3 in
NCC-melb4 cells but not in NCC-melan5 cells. (a) NCC-melb4
cells were incubated with or without 10±7 M 1,25(OH)2D3 for 72 h.
Total RNA was extracted and analyzed by reverse transcription±PCR.
Lanes 1 and 2: b-actin; lanes 3 and 4: EDNRB. (b) NCC-melb4 cells
were incubated with various concentrations of 1,25(OH)2D3 for 72 h.
Total RNA was extracted and analyzed by reverse transcription±PCR.
Lane 1: 10±7 M; lane 2: 10±8 M; lane 3: 10±9 M; lane 4: size marker. (c)
NCC-melan5 cells were incubated with or without 10±7 M
1,25(OH)2D3 for 72 h. Total RNA was extracted and analyzed by
reverse transcription±PCR. Lanes 1 and 2: b-actin; lanes 3 and 4:
EDNRB.
Figure 5. Reverse transcription±PCR analysis of VDR mRNA
expression in NCC-melb4 cells and in NCC-melan5 cells. Total
RNA was reverse-transcribed followed by 40 cycles PCR of cDNA
using the primers described in Materials and Methods. Lane 1: b-actin of
NCC-melb4 cells; lane 2: b-actin of NCC-melan5 cells; lane 3: VDR of
NCC-melb4 cells; lane 4: VDR of NCC-melan5 cells.
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of the MITF gene in the presence of 1,25(OH)2D3. It also appears
that EDNRB induced by 1,25(OH)2D3 functions as the receptor
for EDN3, being capable of signal transduction that effectively
stimulates MITF expression.
There have been several reports of hyperpigmentation resulting
from the combined use of topical calcipotriol (a vitamin D analog)
and phototherapy in patients with psoriasis or vitiligo vulgaris
(Kokelj et al, 1995; GlaÈser et al, 1998; Parsad et al, 1998). Recent
clinical trials demonstrated the ef®cacy of topical calcipotriol
combined with psoralen and ultraviolet A in treating vitiligo
(Yalcin et al, 2001; Ameen et al, 2001; Ermis et al, 2001); however,
the working mechanism of vitamin D in that treatment regimen
remains unknown. In the treatment of vitiligo, repigmentation is
usually perifollicular (Kovacs, 1998), indicating that melanin is
produced by the melanocytes in hair follicles. In our study,
1,25(OH)2D3 induces EDNRB expression in immature melano-
cytes such as NCC-melb4 cells, but not in mature melanocytes
such as NCC-melan5 cells. A melanocyte stem cell-like sub-
Figure 6. Electron microscopy and ultrastructural DOPA staining reveal the development of melanocyte precursors with 1,25(OH)2D3.
Electron microscopy (a,c) and electron microscopic DOPA staining (b,d) of NCC-melb4 cells were made before (a,b) and after (c,d) 72 h of treatment
with 10±7 M 1,25(OH)2D3. Before the treatment, NCC-melb4 cells contained only stage I melanosomes (small arrow) and were DOPA negative. After
the treatment, stage III±IV melanosomes (large arrows) were seen, and both Golgi areas and melanosomes were DOPA-positive. Scale bar = 1 mm.
Figure 7. Induction of MITF mRNA by combined treatment
with 1,25(OH)2D3 and EDN3. Reverse transcription±PCR analysis of
MITF mRNA from NCC-melb4 cells treated with or without 10±7 M
1,25(OH)2D3 and 100 nM EDN3 for 72 h. Lane 1: no addition; lane 2:
1,25(OH)2D3; lane 3: 1,25(OH)2D3 + EDN3; lane 4: size marker.
Figure 8. 1,25(OH)2D3 stimulates the expression of EDNRB in
primary NCC cultures. Neural tubes of C57BL/6 mice were
explanted and cultured with or without 10±7 M 1,25(OH)2D3. The
explants were ®xed at 13 d in culture and were subjected to
immunohistochemical staining for EDNRB. Note that numerous
EDNRB-positive cells (reddish staining) are seen in 1,25(OH)2D3-
treated cells (b), but not in nontreated cells (a).
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population is thought to be present in the bulge region of hair
follicles (Botchkareva et al, 2001). Taken together, we consider that
vitamin D may act to induce immature melanocytes in hair follicles
to produce melanin by stimulating their differentiation and their
expression of EDNRB. Thus, the effects of 1,25(OH)2D3
presented in this study provide some important clues to understand
the roles of vitamin D3 in melanocyte development and
melanogenesis.
It appears that hyperpigmentation is induced not by a calcipotriol
monotherapy, but by a combination of phototherapy plus
calcipotriol, as most patients with psoriasis who are treated with
calcipotriol do not show any increase in skin pigmentation. Then it
is considered that there must be some additional effects of the
phototherapy on the melanocyte signaling that are independent of
the vitamin D effect. EDN secreted by ultraviolet B-exposed
keratinocytes are one of the candidates that cause ultraviolet-
induced hyperpigmentation (Imokawa et al, 1995, 1997). Further
studies using human melanocytes and melanocyte precursors are
necessary, as the results with murine cells may not be directly
applied to human cells.
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